The doctor-led guide to weight loss
Clear, compassionate articles on GLP-1s, safety, side-effects, nutrition, and real-world progress—reviewed by UK-registered clinicians.
Retatrutide weight loss results from Phase 2 and TRIUMPH trials — average loss, month-by-month timeline, and how it compares to Mounjaro and Wegovy.
How big is the UK obesity problem in 2026? The latest data on adult and child prevalence, regional differences, NHS costs, and projections to 2040.
How many people in the UK use weight loss injections? Up-to-date 2026 stats on Mounjaro and Wegovy adoption, NHS rollout, demographics and the private market.
A doctor-led look at Juniper weight loss in the UK — what's in the programme, how much it costs, who it's for, and how it compares with other options.
Three Mounjaro before and after stories from UK patients — what the weight loss looked like, the side effects they faced and what helped them stay on track.
Retatrutide has no approved brand name. Here's what it's actually called (INN, LY3437943, 'triple G'), why, and when a UK brand could appear.